Next Generation Sequencing (NGS) Market by Technology, Competitors, Applications & Tools - Global Trends & Forecasts (2011 - 2016)

Date: April 1, 2012
Pages: 271
Price:
US$ 4,650.00 US$ 3,488.00
Offer valid until December 31, 2014!
License [?]:
Publisher: MarketsandMarkets
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: NE58BE5DAA2EN
Leaflet:

Download PDF Leaflet

Next Generation Sequencing (NGS) Market by Technology (Pyrosequencing & Others), Competitors (Illumina, 454 Roche, Life Science Technologies), Applications and Tools - Global Trends and Forecasts (2011-2016)

Next generation sequencing is the next generation of DNA sequencing which includes several technologies to determine the order of nucleotide bases in a molecule of DNA. It is the fastest growing and the most lucrative segment in the genomics space. With estimated double digit growth, next generation sequencing will revolutionize the medical research in academic laboratories, biopharma, and the applied markets.

The NGS market is dynamic and innovative; it is also paving its ways into the labs which were previously not involved in sequencing. High pace of NGS research is likely to boost the market for personal genome sequencing in the coming years.

The next generation sequencing which was primarily used by large research firms like academics, government research centers is now turning out to be a potential transformative diagnostic tool especially for the oncology studies. This shift from the academics to the clinical and diagnostics lab is mainly due to speedy improvements in the costs and technological capabilities.

The major drivers for the growth of NGS market is advancement of technologies and decrease of price of the tests being conducted with increased promotion made by the research institutions for use of DNA sequencers or NGS technology. Similarly, this technology has overridden the microarray technology and currently many institutes prefer the NGS platforms over microarrays. Similarly, greater interest has been observed in the field of cancer and personalized medicines. As the prices are expected to decrease further in the coming years, NGS testing may be considered for reimbursement under the health insurance policies. Lack of reimbursements, pricing cuts lack of skilled labor is hampering the growth of the NGS market globally. Similarly storage of the data is a major concern for the sequencing industry at present.

North America commanded the largest share of 51.8% of the overall NGS market and was valued at $436 million in 2011. Europe accounted for a share of 31.1% and is expected to grow at a CAGR of 21.1% from 2011 to 2016.

Key players in this market include Illumina (U.S.), Life Technologies (U.S.), 454 Roche (Switzerland), Oxford Nanopore Technologies (U.K.), and Pacific Biosciences (U.S.).

Scope of the report

The report evaluates the NGS market globally with respect to revenue, growth, and industry focus in the following markets:
  • Global NGS market, by technology
    • Pyrosequencing
    • Sequencing by synthesis
    • Sequencing by hybridization
    • Single molecule real time sequencing
  • Global NGS market, by tools/platforms
    • Illumina
      • HISeQ 2000
      • HISeQ 1000
      • GA Iix
      • MiSeq
      • HiScan SQ
    • Roche 454
      • GS-FLX System
      • GS-FLX Junior
    • Life Technologies
      • 5500 SOLiD SERIEs
      • Life SOLiD 4
      • Ion Torrent – PGM
    • Intelligent BioSystems/Azco
      • Max-SeQ
    • Others
  • Global NGS market, by end-user analysis
    • Academics
    • Commercial/industry
    • Non-Profit Organizations
    • Government Organizations
    • Others
  • Global NGS market, by applications
  • Fundamental research
    • Whole Transcriptome Analysis
      • Exome sequencing
      • RNA sequencing
      • Targeted re-sequencing
    • Whole Genome Sequencing
    • Chromatin and RNA Immunoprecipitation Sequencing (CHIP-SEQ)/(RIP-SEQ)
    • Methyl-Seq
  • Applied research
    • Diagnostics
    • Drug discovery
    • Agriculture & animal genomics
    • Personal genomics
    • Other related applications
  • NGS market, by geography
    • North America
    • Europe
    • Asia
    • ROW
Each section of the report offers market data for the various market segments and geographies. It also provides market trends with respect to drivers, restraints, and opportunities.
1 INTRODUCTION

1.1 KEY TAKE-AWAYS
1.2 REPORT DESCRIPTION
1.3 MARKETS COVERED
1.4 STAKEHOLDERS
1.5 RESEARCH METHODOLOGY
  1.5.1 MARKET SIZE
  1.5.2 MARKET SHARE
  1.5.3 KEY DATA POINTS FROM SECONDARY SOURCES
  1.5.4 KEY DATA POINTS FROM PRIMARY SOURCES

2 EXECUTIVE SUMMARY

3 MARKET OVERVIEW

3.1 INTRODUCTION
3.2 EVOLUTION
3.3 MARKET SEGMENTATION
3.4 BURNING ISSUE
  3.4.1 DATA STORAGE AN IMPEDIMENT FOR NGS SEQUENCING
3.5 WINNING IMPERATIVES
  3.5.1 ACCURACY & STANDARDIZATION HAVE TO BE ACHIEVED IF NGS HAS TO BE APPLIED IN DIAGNOSTIC TESTING
  3.5.2 IMPROVED COLLABORATIVE TIES BETWEEN INDUSTRY & ACADEMIC & RESEARCH INSTITUTES
3.6 MARKET DYNAMICS
  3.6.1 DRIVERS
    3.6.1.1 Cost and speed to drive the growth of NGS technology
    3.6.1.2 Switch of microarray technology by NGS in a number of applications within the research community
    3.6.1.3 Growth in embracement of the NGS technology by new consumers
    3.6.1.4 Increase in practice for new scientific applications beyond just sequencing
  3.6.2 RESTRAINTS
    3.6.2.1 Research labs are highly reliant on grants
    3.6.2.2 Decrease in capital expenditure from academic institutes is compelling the service providers to provide an alternative in-house platform adoption
  3.6.3 OPPORTUNITIES
    3.6.3.1 Personalized medicine
    3.6.3.2 Biomarker discovery
  3.6.4 CHALLENGES
    3.6.4.1 Interpretation of complex data from next generation sequencing platforms
    3.6.4.2 Increased in breadth of applications leading to designing of sequencers for longer roads
  3.6.5 MARKET TREND
    3.6.5.1 Shift of focus towards third generation sequencing
3.7 MARKET SHARE ANALYSIS
3.8 END-USER ANALYSIS
3.9 PORTER’S FIVE ANALYSIS
  3.9.1 POTENTIAL ENTRANTS FROM NEW ENTRANTS
  3.9.2 THREAT FROM PRODUCT SUBSTITUTES
  3.9.3 SUPPLIERS’ BARGAINING POWER
  3.9.4 BUYERS BARGAINING POWER
  3.9.5 RIVALRY AMONG EXISTING PLAYERS
3.1 VALUE CHAIN ANALYSIS

4 TECHNOLOGY MARKET

4.1 FIRST GENERATION SEQUENCING
4.2 NEXT GENERATION SEQUENCING
  4.2.1 PYROSEQUENCING
  4.2.2 SEQUENCING BY SYNTHESIS (SBS)
  4.2.3 SEQUENCING BY LIGATION (SBL)
  4.2.4 SEQUENCING BY HYBRIDIZATION (SBH)
  4.2.5 SINGLE MOLECULE REAL TIME SEQUENCING (SMRT)

5 NGS MARKET, BY SEQUENCING TOOLS

5.1 INTRODUCTION
5.2 ILLUMINA
  5.2.1 HISEQ 2000
  5.2.2 HISEQ 1000
  5.2.3 GA IIX
  5.2.4 MISEQ
  5.2.5 HISCAN SQ
5.3 LIFE TECHNOLOGIES
  5.3.1 5500 SOLID SERIES
  5.3.2 LIFE SOLID 4
  5.3.3 ION TORRENT – PGM (LIFE TECHNOLOGIES)
5.4 (454) ROCHE
  5.4.1 GS-FLX SYSTEM
  5.4.2 GS-FLX JUNIOR
5.5 INTELLIGENT BIOSYSTEMS/AZCO
  5.5.1 MAX-SEQ
5.6 OTHERS

6 APPLICATIONS MARKET

6.1 INTRODUCTION
6.2 FUNDAMENTAL RESEARCH
  6.2.1 GENOME
    6.2.1.1 Whole genome sequencing
    6.2.1.2 De novo sequencing
    6.2.1.3 Targeted re-sequencing
  6.2.2 TRANSCRIPTOME
    6.2.2.1 Whole transcriptome analysis
    6.2.2.2 Exome sequencing
    6.2.2.3 RNA sequencing
  6.2.3 EPIGENOME
    6.2.3.1 Methyl-Seq
    6.2.3.2 ChIP-Seq
  6.2.4 METAGENOME
    6.2.4.1 Environmental
    6.2.4.2 Human microbiome
6.3 APPLIED RESEARCH
  6.3.1 DIAGNOSTICS
  6.3.2 DRUG DISCOVERY
  6.3.3 BIOMARKER DISCOVERY
  6.3.4 PERSONALIZED MEDICINE
  6.3.5 AGRICULTURE & ANIMAL
  6.3.6 OTHERS

7 GEOGRAPHICAL ANALYSIS

7.1 INTRODUCTION
7.2 NORTH AMERICA
7.3 EUROPE
7.4 ASIA
7.5 ROW

8 COMPETITIVE LANDSCAPE

8.1 INTRODUCTION
8.2 MERGERS & ACQUISITIONS, 2009 – 2011
8.3 AGREEMENTS & COLLABORATIONS, 2009 – 2012
8.4 NEW PRODUCTS LAUNCH, 2009 – 2012
8.5 EXPANSIONS, 2009 – 2011
8.6 OTHER DEVELOPMENTS, 2009 – 2012

9 COMPANY PROFILES

9.1 23ANDME INC
  9.1.1 OVERVIEW
  9.1.2 FINANCIALS
  9.1.3 PRODUCTS & SERVICES
  9.1.4 STRATEGY
  9.1.5 DEVELOPMENTS
9.2 AFFYMETRIX INC
  9.2.1 OVERVIEW
  9.2.2 FINANCIALS
  9.2.3 PRODUCTS & SERVICES
  9.2.4 STRATEGY
  9.2.5 DEVELOPMENTS
9.3 BIOTEAM INC
  9.3.1 OVERVIEW
  9.3.2 FINANCIALS
  9.3.3 PRODUCT & SERVICES
  9.3.4 STRATEGY
  9.3.5 DEVELOPMENTS
9.4 DECODE GENETICS
  9.4.1 OVERVIEW
  9.4.2 PRODUCTS & SERVICES
  9.4.3 STRATEGY
  9.4.4 DEVELOPMENTS
9.5 DNASTAR INC
  9.5.1 OVERVIEW
  9.5.2 FINANCIALS
  9.5.3 PRODUCTS & SERVICES
  9.5.4 STRATEGY
  9.5.5 DEVELOPMENTS
9.6 GATC BIOTECH AG
  9.6.1 OVERVIEW
  9.6.2 FINANCIALS
  9.6.3 PRODUCTS & SERVICES
  9.6.4 STRATEGY
  9.6.5 DEVELOPMENTS
9.7 GENOMEQUEST INC
  9.7.1 OVERVIEW
  9.7.2 FINANCIALS
  9.7.3 PRODUCTS & SERVICES
  9.7.4 STRATEGY
  9.7.5 DEVELOPMENTS
9.8 HELICOS BIOSCIENCES CORPORATION
  9.8.1 OVERVIEW
  9.8.2 FINANCIALS
  9.8.3 PRODUCTS & SERVICES
  9.8.4 STRATEGY
  9.8.5 DEVELOPMENTS
9.9 ILLUMINA INC
  9.9.1 OVERVIEW
  9.9.2 FINANCIALS
  9.9.3 PRODUCTS & SERVICES
  9.9.4 STRATEGY
  9.9.5 DEVELOPMENTS
9.1 INTELLIEGENT BIO-SYSTEMS INC
  9.10.1 OVERVIEW
  9.10.2 FINANCIALS
  9.10.3 PRODUCTS & SERVICES
  9.10.4 STRATEGY
  9.10.5 DEVELOPMENTS
9.11 KNOME INC
  9.11.1 OVERVIEW
  9.11.2 FINANCIALS
  9.11.3 PRODUCTS & SERVICES
  9.11.4 STRATEGY
  9.11.5 DEVELOPMENTS
9.12 LIFE TECHNOLOGIES CORPORATION
  9.12.1 OVERVIEW
  9.12.2 FINANCIALS
  9.12.3 PRODUCTS & SERVICES
  9.12.4 SERVICES
  9.12.5 STRATEGY
  9.12.6 DEVELOPMENTS
9.13 NAVIGENICS INC
  9.13.1 OVERVIEW
  9.13.2 FINANCIALS
  9.13.3 PRODUCTS & SERVICES
  9.13.4 STRATEGY
  9.13.5 DEVELOPMENTS
9.14 OXFORD NANOPORE TECHNOLOGIES LTD
  9.14.1 OVERVIEW
  9.14.2 FINANCIALS
  9.14.3 PRODUCTS & SERVICES
  9.14.4 STRATEGY
  9.14.5 DEVELOPMENTS
9.15 PACIFIC BIOSCIENCES INC
  9.15.1 OVERVIEW
  9.15.2 FINANCIALS
  9.15.3 PRODUCTS & SERVICES
  9.15.4 STRATEGY
  9.15.5 DEVELOPMENTS
9.16 SEQWRIGHT INC
  9.16.1 OVERVIEW
  9.16.2 FINANCIALS
  9.16.3 PRODUCTS & SERVICES
  9.16.4 STRATEGY
  9.16.5 DEVELOPMENTS

LIST OF TABLES

TABLE 1 GLOBAL NGS MARKET REVENUE, BY TECHNOLOGY, 2009 - 2016 ($MILLION)
TABLE 2 COMPARISON BETWEEN NEXT GENERATION SEQUENCING & MICROARRAY
TABLE 3 GLOBAL NGS TECHNOLOGY, BY COMPANY
TABLE 4 PYROSEQUENCING TECHNOLOGY MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
TABLE 5 SBS TECHNOLOGY MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
TABLE 6 SBL TECHNOLOGY MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
TABLE 7 SBH TECHNOLOGY MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
TABLE 8 SMRT MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
TABLE 9 GLOBAL NGS SEQUENCING MARKET REVENUE, BY TOOLS, 2009 - 2016 ($MILLION)
TABLE 10 HISEQ 2000: PRODUCT PORTFOLIO
TABLE 11 HISEQ 2000: NGS MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
TABLE 12 HISEQ 1000: PRODUCT PORTFOLIO
TABLE 13 HISEQ 1000: NGS MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
TABLE 14 GA IIX: PRODUCT PORTFOLIO
TABLE 15 GA IIX: NGS MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
TABLE 16 MISEQ: PRODUCT PORTFOLIO
TABLE 17 MISEQ: NGS MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
TABLE 18 HISCAN SQ: PRODUCT PORTFOLIO
TABLE 19 HISCAN SQ: NGS MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
TABLE 20 5500 & 5500XL SERIES: PRODUCT PORTFOLIO
TABLE 21 5500 XL SOLID: NGS MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
TABLE 22 5500 SOLID: NGS MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
TABLE 23 LIFE SOLID 4: PRODUCT PORTFOLIO
TABLE 24 LIFE SOLID 4: NGS MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
TABLE 25 ION TORRENT: NGS MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
TABLE 26 GS-FLX SYSTEM: PRODUCT PORTFOLIO
TABLE 27 GS FLX: NGS MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
TABLE 28 GS-FLX JUNIOR: PRODUCT PORTFOLIO
TABLE 29 GS JUNIOR: NGS MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
TABLE 30 MAX-SEQ: NGS MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
TABLE 31 OTHERS: NGS MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
TABLE 32 GLOBAL FUNDAMENTAL RESEARCH NGS MARKET REVENUE, BY APPLICATIONS, 2009 - 2016 ($MILLION)
TABLE 33 GLOBAL GENOME NGS MARKET REVENUE, BY APPLICATIONS, 2009 - 2016 ($MILLION)
TABLE 34 WHOLE GENOME SEQUENCING NGS MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
TABLE 35 DE NOVO SEQUENCING NGS MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
TABLE 36 TARGETED RE-SEQUENCING NGS MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
TABLE 37 GLOBAL TRANSCRIPTOME NGS MARKET REVENUE, BY APPLICATIONS, 2009 - 2016 ($MILLION)
TABLE 38 WHOLE TRANSCRIPTOME NGS MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
TABLE 39 EXOME SEQUENCING NGS MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
TABLE 40 RNA SEQUENCING NGS MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
TABLE 41 GLOBAL EPIGENOME SEQUENCING NGS MARKET REVENUE, BY APPLICATIONS, 2009 - 2016 ($MILLION)
TABLE 42 METHYL SEQUENCING NGS MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
TABLE 43 CHIP SEQUENCING NGS MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
TABLE 44 GLOBAL METAGENOME SEQUENCING NGS MARKET REVENUE, BY APPLICATIONS, 2009 - 2016 ($MILLION)
TABLE 45 ENVIRONMENTAL SEQUENCING NGS MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
TABLE 46 HUMAN MICROBIOME SEQUENCING NGS MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
TABLE 47 GLOBAL APPLIED RESEARCH NGS MARKET REVENUE, BY APPLICATIONS, 2009 - 2016 ($MILLION)
TABLE 48 DIAGNOSTICS NGS MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
TABLE 49 DRUG DISCOVERY NGS MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
TABLE 50 BIOMARKER DISCOVERY NGS MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
TABLE 51 PERSONALIZED MEDICINE NGS MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
TABLE 52 AGRICULTURE & ANIMAL NGS MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
TABLE 53 OTHERS NGS MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
TABLE 54 NGS MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
TABLE 55 NORTH AMERICA: NGS MARKET REVENUE, BY TECHNOLOGY, 2009 - 2016 ($MILLION)
TABLE 56 NORTH AMERICA: NGS MARKET REVENUE, BY TOOLS, 2009 - 2011 ($MILLION)
TABLE 57 NORTH AMERICA: NGS FUNDAMENTAL RESEARCH MARKET REVENUE, BY APPLICATIONS, 2009 - 2016 ($MILLION)
TABLE 58 NORTH AMERICA: GENOME RESEARCH NGS MARKET REVENUE, BY APPLICATIONS, 2009 - 2016 ($MILLION)
TABLE 59 NORTH AMERICA: TRANSCRIPTOME RESEARCH NGS MARKET REVENUE, BY APPLICATIONS, 2009 - 2016 ($MILLION)
TABLE 60 NORTH AMERICA: EPIGENOME RESEARCH NGS MARKET REVENUE, BY APPLICATIONS, 2009 - 2016 ($MILLION)
TABLE 61 NORTH AMERICA: METAGENOMEGENOME RESEARCH NGS MARKET REVENUE, BY APPLICATIONS, 2009 - 2016 ($MILLION)
TABLE 62 NORTH AMERICA: APPLIED RESEARCH NGS MARKET REVENUE, BY APPLICATIONS, 2009 - 2016 ($MILLION)
TABLE 63 EUROPE: NGS MARKET REVENUE, BY TECHNOLOGY, 2009 - 2016 ($MILLION)
TABLE 64 EUROPE: NGS MARKET REVENUE, BY TOOLS, 2009 - 2011 $MILLION)
TABLE 65 EUROPE: FUNDAMENTAL RESEARCH NGS MARKET REVENUE, BY APPLICATIONS, 2009 - 2016 ($MILLION)
TABLE 66 EUROPE: GENOME RESEARCH NGS MARKET REVENUE, BY APPLICATIONS, 2009 - 2016 ($MILLION)
TABLE 67 EUROPE: TRANSCRIPTOME RESEARCH NGS MARKET REVENUE, BY APPLICATIONS, 2009 - 2016 ($MILLION)
TABLE 68 EUROPE: EPIGENOME RESEARCH NGS MARKET REVENUE, BY APPLICATIONS, 2009 - 2016 ($MILLION)
TABLE 69 EUROPE: METAGENOMEGENOME RESEARCH NGS MARKET REVENUE, BY APPLICATIONS, 2009 - 2016 ($MILLION)
TABLE 70 EUROPE: APPLIED RESEARCH NGS MARKET REVENUE, BY APPLICATIONS, 2009 - 2016 ($MILLION)
TABLE 71 ASIA: NGS MARKET REVENUE, BY TECHNOLOGY, 2009 - 2016 ($MILLION)
TABLE 72 ASIA: NGS MARKET REVENUE, BY TOOLS,2009 - 2011,($MILLION)
TABLE 73 ASIA: FUNDAMENTAL RESEARCH NGS MARKET REVENUE, BY APPLICATIONS, 2009 - 2016 ($MILLION)
TABLE 74 ASIA: GENOME RESEARCH NGS MARKET REVENUE, BY APPLICATIONS, 2009 - 2016 ($MILLION)
TABLE 75 ASIA: TRANSCRIPTOME RESEARCH NGS MARKET REVENUE, BY APPLICATIONS, 2009 - 2016 ($MILLION)
TABLE 76 ASIA: EPIGENOME RESEARCH NGS MARKET REVENUE, BY APPLICATIONS, 2009 - 2016 ($MILLION)
TABLE 77 ASIA: METAGENOMEGENOME RESEARCH NGS MARKET REVENUE, BY APPLICATIONS, 2009 - 2016 ($MILLION)
TABLE 78 ASIA: APPLIED RESEARCH MARKET REVENUE, BY APPLICATIONS, 2009 - 2016 ($MILLION)
TABLE 79 ROW: NGS MARKET REVENUE, BY TECHNOLOGY, 2009 - 2016 ($MILLION)
TABLE 80 ROW: NGS MARKET REVENUE, BY TOOLS, 2009 - 2011 ($MILLION)
TABLE 81 ROW: FUNDAMENTAL RESEARCH NGS MARKET REVENUE, BY APPLICATIONS, 2009 - 2016 ($MILLION)
TABLE 82 ROW: GENOME RESEARCH APPLICATIONS NGS MARKET REVENUE, BY APPLICATIONS, 2009 - 2016 ($MILLION)
TABLE 83 ROW: TRANSCRIPTOME RESEARCH NGS MARKET REVENUE, BY APPLICATIONS, 2009 - 2016 ($MILLION)
TABLE 84 ROW: EPIGENOME RESEARCH NGS MARKET REVENUE, BY APPLICATIONS, 2009 - 2016 ($MILLION)
TABLE 85 ROW: METAGENOMEGENOME RESEARCH NGS MARKET REVENUE, BY APPLICATIONS, 2009 - 2016 ($MILLION)
TABLE 86 ROW: APPLIED RESEARCH NGS MARKET REVENUE, BY APPLICATIONS, 2009 - 2016 ($MILLION)
TABLE 87 AFFYMETRIX INC.: TOTAL REVENUE AND R&D EXPENSES, 2009 - 2011 ($MILLION)
TABLE 88 AFFYMETRIX: TOTAL REVENUE, BY SEGMENTS, 2009 - 2011 ($MILLION)
TABLE 89 AFFYMETRIX: TOTAL REVENUE, BY GEOGRAPHY, 2009 - 2011 ($MILLION)
TABLE 90 HELICOSE: TOTAL REVENUE AND R&D EXPENSES, 2008 - 2010 ($MILLION)
TABLE 91 HELICOS: TOTAL REVENUE, BY SEGMENTS, 2008 - 2010 ($MILLION)
TABLE 92 ILLUMINA: TOTAL REVENUE AND R&D EXPENSES, 2009 - 2011 ($MILLION)
TABLE 93 ILLUMINA: TOTAL REVENUE, BY SEGMENTS, 2009 - 2011 ($MILLION)
TABLE 94 ILLUMINA: TOTAL REVENUE, BY GEOGRAPHY, 2009 - 2011 ($MILLION)
TABLE 95 LIFE TECHNOLOGIES: TOTAL REVENUE AND R&D EXPENSES, 2009 - 2011 ($MILLION)
TABLE 96 LIFE TECHNOLOGIES: TOTAL REVENUE, BY SEGMENTS, 2009 - 2011 ($MILLION)
TABLE 97 LIFE TECHNOLOGIES: TOTAL REVENUE, BY GEOGRAPHY, 2009 - 2011 ($MILLION)
TABLE 98 PACIFIC BIOSCIENCES: TOTAL REVENUE AND R&D EXPENSES, 2009 - 2011 ($MILLION)
TABLE 99 PACIFIC BIOSCIENCES: TOTAL REVENUE, BY SEGMENTS, 2009 - 2011 ($MILLION)
TABLE 100 PACIFIC BIOSCIENCES: TOTAL REVENUE, BY GEOGRAPHY, 2009 - 2011 ($MILLION)

LIST OF FIGURES

FIGURE 1 EVOLUTION OF GENETIC ANALYSIS
FIGURE 2 NGS MARKET SEGMENTATION
FIGURE 3 DATA STORAGE & PRICING, 1990 – 2012
FIGURE 4 GLOBAL NGS MARKET SHARE, BY COMPANY, 2011
FIGURE 5 GLOBAL NGS MARKET SHARE, BY END-USERS, 2011
FIGURE 6 PORTER’S FIVE ANALYSIS FOR SEQUENCING TOOLS INDUSTRY
FIGURE 7 VALUE CHAIN ANALYSIS FOR SEQUENCING PLATFORMS
FIGURE 8 PROCESS OF DNA SEQUENCING
FIGURE 9 WORKFLOW OF HISEQ 2000 PLATFORM
FIGURE 10 NGS MARKET, BY APPLICATIONS
FIGURE 11 STEPS IN WHOLE GENOME SEQUENCING
FIGURE 12 TARGETED RE-SEQUENCING, BY TYPES
FIGURE 13 CHIP-SEQ METHOD
FIGURE 14 METAGENOME PROCESS
FIGURE 15 KEY GROWTH STRATEGIES, 2009 - 2011

Ask Your Question

Next Generation Sequencing (NGS) Market by Technology, Competitors, Applications & Tools - Global Trends & Forecasts (2011 - 2016)
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry: